Philip Urban
- Interventional Cardiologist at the Hopital de la Tour, Meyrin-Genève - Switzerland
- Medical co-director of the CERC, Paris - France
- Chairman of the Fondation Coeur de la Tour (2005)
- Commitment to enabling interventional care in cooperation with the B.P. Koirala Institute of Health Sciences (BPKIHS) in Dharan, Nepal
Latest contributions
Ostial LAD - Ostial circumflex
15 May 2024 – From EuroPCR 2024
Left main coronary interventions from basics to stenting techniques
15 May 2024 – From EuroPCR 2024
Endovascular treatment for acute chronic heart failure
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex endovascular cases for the treatment of acute chronic heart failure, including the use of 3D printing and virtual reality to close a pulmonary arteriovenous malformation, closure of a post-septal myectomy ventricular septal defect, and catheter-based treatment of a heart...
Latest trends in PCI - Stentless PCI and the role of sustained limus release
17 May 2023 – From EuroPCR 2023
Explore the latest trends in percutaneous coronary intervention (PCI) in this session, focusing on stentless PCI and the role of sustained limus release technology. Join the discussion on how sustained limus release can expand the indications for drug-eluting balloons (DEB) and minimize the use of metal...
EuroPCR 2023 Hotlines/Late-Breaking clinical data: focus on left main and bifurcation PCI
16 May 2023 – From EuroPCR 2023
Listen to the presenters give you the latest information on left main and bifurcation from a series of late-breaking trials presented at EuroPCR 2023:
- The five-year follow-up of the EBC TWO 5-year follow-up study, which evaluated provisional versus culotte intervention for coronary bifurcations
- KISS: the benefit...
Evidence based PCI in patients at high bleeding risk – The LEADERS FREE trials
Watch this video to understand the importance of high bleeding risk, the safety and efficacy of polymer-free BA9-coated coronary stents and the impact of a new thin strut CoCr stent platform on clinical outcomes.
Speakers: Keith Oldroyd, Philip Urban, Franz Eberli
This interview supported by Biosensors Europe SA ...
Hot line on PCI: high bleeding risk and DAPT - part 1
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ARC-HBR, MODEL U-SES, Onyx ONE trials.
High-bleeding risk patients: Guidelines and recommendations from the ARC HBR initiative
Philip Urban and Davide Capodanno outline the rationale behind the Academic Research Consortium for High Bleeding Risk (ARC-HBR) consensus document on defining high bleeding risk in patients undergoing percutaneous coronary intervention (PCI). They explain why a standardised definition of high bleeding risk was becoming “increasingly urgent”...
High-bleeding risk PCI patients enrolled in ongoing clinical trials
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about high-bleeding risk PCI patients: how to identify them, how to successfully adapt PCI technique and how to select the optimal antiplatelet treatment post-PCI according to the patient's bleeding and thrombotic risks.
EuroPCR 2019 Press Release: A pragmatic approach to defining high bleeding risk for patients undergoing in PCI
22 May 2019
Paris, France, 22 May 2019. Identification and management of patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI) is of major importance, but a lack of standardisation in defining this population limits trial design, data interpretation, and clinical decision-making.
TAVI in horizontal aorta
22 May 2019 – From EuroPCR 2019
Consult this session to discover a LIVE demonstration from St. Johannes Hospital - Dortmund, Germany, regarding TAVI in horizontal aorta, transmitted live during EuroPCR 2019. The patient here is a 78 years-old male presenting with progressive dyspnea (NYHA III) and angina pectoris (CCS-III), whose echography shows...
An image is worth a 1,000 words
22 May 2019 – From EuroPCR 2019
Consult this session to discover some of the most puzzling images out of those submitted for EuroPCR 2019.
Keynote lecture: Defining high bleeding risk in patients undergoing PCI: a consensus from the Academic Research Consortium for high bleeding risk
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about high bleeding risk in patients undergoing PCI with this study from the Academic Research Consortium.
All you need to know about high-bleeding risk (HBR) patients
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about current evidence and new recommendations on high bleeding risk patients and how to better identify them.
How to manage PCI in patients treated with oral anticoagulant?
22 May 2019 – From EuroPCR 2019
Consult this session to learn how to decide between different combinations of antithrombotic agents after PCI and how to manage high ischaemic risk patients treated with oral anticoagulant.
Andreas Grüntzig Ethica Awardees
19 Jul 2017
Discover the list of all the Andreas Grüntzig Ethica Awardees.
